First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: Clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD group study.
Times cited: 41
Approach to early-onset colorectal cancer: Clinicopathological, familial, molecular and immunohistochemical characteristics.
World Journal of Gastroenterology.
Times cited: 32
Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.
Journal of Clinical Oncology.
Times cited: 172